Comparison of embryo implantation potential between time-lapse incubators and standard incubators: a randomized controlled study.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
11 2022
Historique:
received: 07 02 2022
revised: 09 06 2022
accepted: 20 06 2022
pubmed: 10 10 2022
medline: 8 11 2022
entrez: 9 10 2022
Statut: ppublish

Résumé

What are the potential clinical benefits of embryo culture and assessment in a time-lapse incubator compared with a standard incubator using static assessment? This large multicentre, single-blinded, randomized controlled study included 1224 participants randomly assigned (1:1) to the time-lapse or standard incubator group. In all patients one or two embryos were transferred on day 3. The primary outcome was the implantation rate in the first embryo transfer cycle. Secondary outcomes included the cumulative implantation rate, live birth rate in the first embryo transfer cycle and cumulative live birth rate. Among 1224 participants recruited, 1182 underwent embryo transfer. The number of successfully implanted embryos in the first transfer cycle was significantly higher in the time-lapse incubator group (time-lapse group: 52.35%, standard incubator group: 47.11%, P = 0.014). The implantation rate in the first embryo transfer cycle was still significantly higher in the time-lapse group than the standard incubator group after adjusting for age, body mass index, medical centre and embryo status (relative risk 1.11, 95% confidence interval 1.02-1.20, P = 0.020). However, the cumulative implantation rate, live birth rate in the first embryo transfer cycle and cumulative live birth rate were not statistically different between the groups. The implantation rate in the first embryo transfer cycle was significantly improved in the time-lapse group, but the effect of the time-lapse system on the cumulative implantation rate or cumulative live birth rate was not significant. The embryo assessment method offered by time-lapse systems rather than an undisturbed environment may play an important role in improving the implantation rate in the first embryo transfer cycle. These results are only applicable to young patients.

Identifiants

pubmed: 36210273
pii: S1472-6483(22)00429-1
doi: 10.1016/j.rbmo.2022.06.017
pii:
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

858-866

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Auteurs

Xiao-Dong Zhang (XD)

Chongqing Key Laboratory of Human Embryo Engineering Chongqing, China; Center for Reproductive Medicine, Reproductive and Genetic Institute, Women and Children's Hospital of Chongqing Medical University Chongqing, China.

Qi Zhang (Q)

Chongqing Key Laboratory of Human Embryo Engineering Chongqing, China; Center for Reproductive Medicine, Reproductive and Genetic Institute, Women and Children's Hospital of Chongqing Medical University Chongqing, China.

Wei Han (W)

Chongqing Key Laboratory of Human Embryo Engineering Chongqing, China; Center for Reproductive Medicine, Reproductive and Genetic Institute, Women and Children's Hospital of Chongqing Medical University Chongqing, China.

Wei-Wei Liu (WW)

Chongqing Key Laboratory of Human Embryo Engineering Chongqing, China; Center for Reproductive Medicine, Reproductive and Genetic Institute, Women and Children's Hospital of Chongqing Medical University Chongqing, China.

Xiao-Li Shen (XL)

Chongqing Key Laboratory of Human Embryo Engineering Chongqing, China; Center for Reproductive Medicine, Reproductive and Genetic Institute, Women and Children's Hospital of Chongqing Medical University Chongqing, China.

Gui-Dong Yao (GD)

IVF Clinical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.

Sen-Lin Shi (SL)

IVF Clinical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.

Lin-Li Hu (LL)

IVF Clinical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China.

Shan-Shan Wang (SS)

Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing Jiangsu, China.

Jun-Xia Wang (JX)

Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing Jiangsu, China.

Jian-Jun Zhou (JJ)

Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing Jiangsu, China.

Wei-Wei Kang (WW)

Department of Obstetrics and Gynaecology, Tangdu Hospital, Air Force Medical University, Xi-an Shanxi, China.

Heng-De Zhang (HD)

Department of Obstetrics and Gynaecology, Tangdu Hospital, Air Force Medical University, Xi-an Shanxi, China.

Chen Luo (C)

IVF Clinical Center, Nanfang Hospital, Southern Medical University, Guangzhou Guangdong, China.

Qi Yu (Q)

IVF Clinical Center, Peking Union Medical College Hospital, Dongcheng District Beijing, China.

Rui-Zhi Liu (RZ)

IVF Clinical Center, The First Bethune Hospital of Jilin University, Changchun Jilin, China.

Ying-Pu Sun (YP)

IVF Clinical Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou Henan, China. Electronic address: syp2008@vip.sina.com.

Hai-Xiang Sun (HX)

Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing Jiangsu, China. Electronic address: stevensun@163.com.

Xiao-Hong Wang (XH)

Department of Obstetrics and Gynaecology, Tangdu Hospital, Air Force Medical University, Xi-an Shanxi, China. Electronic address: wangxh-99919@163.com.

Song Quan (S)

IVF Clinical Center, Nanfang Hospital, Southern Medical University, Guangzhou Guangdong, China. Electronic address: quansong@smu.edu.cn.

Guo-Ning Huang (GN)

Chongqing Key Laboratory of Human Embryo Engineering Chongqing, China; Center for Reproductive Medicine, Reproductive and Genetic Institute, Women and Children's Hospital of Chongqing Medical University Chongqing, China. Electronic address: gnhuang217@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH